Linked Life Data

12680177

Source:http://linkedlifedata.com/resource/pubmed/id/12680177

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1B
pubmed:dateCreated
2003-4-8
pubmed:abstractText
To evaluate the efficacy and safety of weekly paclitaxel and trastuzumab in patients with HER2-positive metastatic breast cancer, with trastuzumab administered beyond disease progression.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0250-7005
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
737-44
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:articleTitle
Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer.
pubmed:affiliation
Oncology Department, Henry Dynan Hospital, Athens, Greece. hecogiat@otenet.gr
pubmed:publicationType
Journal Article, Clinical Trial, Clinical Trial, Phase II